Bausch + Lomb ($BLCO) Stock Forecast: Down 14.7% Today

What is Bausch + Lomb?

Bausch + Lomb (BLCO) is a well-known eye health company that offers a wide range of products such as contact lenses, solutions, and pharmaceuticals. The stock is listed on the NYSE.

Why is Bausch + Lomb going down?

BLCO stock is down 14.7% on Apr 30, 2025 17:01

• BLCO reported a significant loss in Q1 and missed revenue estimates, leading to a bearish movement in the stock.
• The negative earnings surprise of -333.33% and slight revenue miss of 0.86% likely contributed to investor concerns and selling pressure.
• The broader market sentiment, with U.S. stock futures slightly lower and other big stocks like Eagle Financial Services also moving lower, added to the downward pressure on BLCO.
• Investors may be cautious about the company's future performance based on the disappointing financial results, prompting them to sell off their positions in BLCO.

BLCO Price Chart

BLCO Technical Analysis

BLCO News

Bausch + Lomb ( BLCO ) Reports Q1 Loss, Misses Revenue Estimates

Bausch + Lomb (BLCO) delivered earnings and revenue surprises of -333.33% and 0.86%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2458662/bausch-lomb-blco-reports-q1-loss-misses-revenue-estimates

Eagle Financial Services, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Bausch & Lomb ( NYSE:BLCO ) , AleAnna ( NASDAQ:ANNA )

U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Monday. Shares of Eagle Financial Services, Inc. EFSI fell sharply in today's pre-market trading after the company released financial results for the first quarter.

https://www.benzinga.com/trading-ideas/movers/25/04/45037323/eagle-financial-services-nvidia-and-other-big-stocks-moving-lower-in-mondays-pre-market-sess

Trending Today

Avalanche ($AVAX) Crypto Forecast: Up 5.4% Today

Cardano ($ADA) Crypto Forecast: Up 5.0% Today

Dogecoin ($DOGE) Crypto Forecast: Up 5.2% Today

Bonk ($BONK) Crypto Forecast: Down 5.4% Today

Litecoin ($LTC) Crypto Forecast: Up 6.5% Today

Monero ($XMR) Crypto Forecast: Down 5.4% Today

Wormhole ($W) Crypto Forecast: Up 5.2% Today

Sei ($SEI) Crypto Forecast: Up 6.7% Today

Worldcoin ($WLD) Crypto Forecast: Down 7.9% Today

Movement ($MOVE) Crypto Forecast: Down 17.7% Today

Bausch + Lomb Price History

18.08.2024 - BLCO Stock was up 14.3%

• BLCO stock surged 14.5% in the last trading session, reaching $17.80, with a significant increase in trading volume.
• Speculation around a potential sale of Bausch + Lomb is circulating, which could lead to a windfall for Bausch Health investors, as suggested by hedge fund managers.
• The surge in BLCO's stock price could be attributed to the news of a possible sale, which is seen as a strategic move to address separation challenges from its parent company, Bausch Health Companies.
• Investors are optimistic about the future potential gains for BLCO, as indicated by the recent strong bullish movement and the ongoing discussions regarding the company's restructuring efforts.

18.08.2024 - BLCO Stock was up 9.6%

• BLCO shares surged by 14.5% in the last trading session, indicating strong investor interest and positive market sentiment.
• Speculation circulates that Bausch + Lomb is contemplating a sale as part of its efforts to address separation challenges from its parent company, Bausch Health Companies. This possibility may have sparked optimism among investors regarding potential strategic moves and value unlocking.
• The company's stock performance was also influenced by the FDA communication that an advisory committee meeting would no longer be required for Applied Therapeutics, Inc. (APLT), which could have had a positive spillover effect on related healthcare stocks like BLCO.
• Despite the recent surge, it's essential to note that the latest trend in earnings estimate revisions for BLCO does not suggest further strength down the road, indicating a need for cautious optimism among investors.

24.03.2025 - BLCO Stock was up 5.1%

• BLCO's stock showed significant bullish movement today.
• Comparisons with DHR may have triggered investor interest and confidence in BLCO's value proposition.
• Despite concerns of a possible decline in earnings, which may have already been factored in by the market, it led to a positive surprise and boosted the stock's performance.
• Investors seem to be focusing on BLCO's long-term growth potential over short-term earnings worries, fueling the bullish momentum.

10.03.2025 - BLCO Stock was down 5.0%

• Despite a 13.9% increase in the previous session, the stock experienced a substantial bearish movement, potentially signaling a trend reversal.
• Investor sentiment may have been influenced by recent changes in earnings estimates, prompting profit-taking and a notable sell-off.
• The absence of consistent momentum in the short term likely played a role in the stock's decline as investors reviewed their BLCO positions.
• The cautious behavior of market participants regarding the stock's future performance appears to have led to the bearish movement observed today.

21.01.2024 - BLCO Stock was up 13.8%

• BLCO stock soared after unveiling fourth-quarter sales that outperformed expectations by 18% year-over-year, particularly driven by strong growth in pharmaceutical revenues.
• The CEO's encouraging forecasts regarding revenue expansion in 2023 and 2024 bolstered investor confidence in the company's future performance.
• The recent appointment of a former Bausch & Lomb executive to a key position at Water Street Healthcare Partners is seen as a positive development for BLCO, signaling ongoing industry expertise and potential avenues for growth.

12.03.2024 - BLCO Stock was down 6.2%

• The comparison between BLCO and Avantor, Inc. might have highlighted potential weaknesses in BLCO's financials or growth prospects, leading to a sell-off by investors.
• Value investors may have shifted their focus towards AVTR, perceiving it as a better investment opportunity compared to BLCO.
• This shift in investor sentiment, coupled with any specific negative news or developments related to BLCO, could have contributed to the bearish movement in the stock today.

22.01.2024 - BLCO Stock was up 8.0%

• BLCO stock surged following the announcement of better-than-expected earnings and revenue for the fourth quarter of 2023, accompanied by an 18% year-on-year sales increase.
• The company's positive performance was driven by a notable increase in pharmaceutical sales, surpassing profit and sales projections.
• CEO Brent Saunders' positive revenue growth outlook for 2023 and 2024 boosted investor confidence, resulting in an 11% increase in the stock price.
• Despite unusual options activity suggesting bearish sentiment towards Bausch Health Companies (BHC), BLCO continued on its upward trend as investors focused on the company's strong financial results and growth potential.

24.06.2024 - BLCO Stock was down 4.4%

• The bearish movement in BLCO's stock today could be attributed to analysts' estimates of a decline in earnings for the company.
• Investors might be reacting to the lack of positive indicators for a potential earnings beat in BLCO's upcoming report, leading to a sell-off of the stock.
• This news has likely influenced market sentiment towards BLCO, causing a significant downward movement in its stock price today.

02.07.2024 - BLCO Stock was down 5.6%

• Despite matching Q2 earnings estimates, the stock had a bearish movement, possibly disappointing investors who may have been anticipating stronger performance.
• The earnings report revealed a 0% surprise in earnings and a 4.11% revenue surprise, which could have contributed to investor disappointment over the lack of robust growth indicators.
• The unclear signals in the earnings report regarding future outlook may have left investors apprehensive about the company's prospects.
• Market sentiment towards BLCO may have been influenced by various factors beyond the earnings report, possibly including broader market conditions and industry trends.

30.03.2025 - BLCO Stock was down 20.4%

• BLCO experienced a strong bearish movement today.
• The pre-market session showed big stocks like Eagle Financial Services falling sharply, indicating a broader negative sentiment in the market.
• The comparison between BLCO and DHR in terms of value might have influenced investor decisions, potentially leading to a sell-off of BLCO shares.
• Analysts estimating a decline in BLCO's earnings could have further contributed to the bearish movement as investors adjusted their positions based on these expectations.

19.01.2025 - BLCO Stock was up 0.0%

• BLCO stock saw significant upward movement today.
• The company exceeded both earnings and revenue projections for the fourth quarter of 2024, indicating robust financial performance.
• The market responded favorably to the outperformance, reflecting confidence in BLCO's growth potential.
• The positive market sentiment towards BLCO is likely influenced by its strong financial results and growth opportunities.

30.03.2025 - BLCO Stock was down 14.7%

• BLCO reported a significant loss in Q1 and missed revenue estimates, leading to a bearish movement in the stock.
• The negative earnings surprise of -333.33% and slight revenue miss of 0.86% likely contributed to investor concerns and selling pressure.
• The broader market sentiment, with U.S. stock futures slightly lower and other big stocks like Eagle Financial Services also moving lower, added to the downward pressure on BLCO.
• Investors may be cautious about the company's future performance based on the disappointing financial results, prompting them to sell off their positions in BLCO.